FDA Inspection 1222371 — Blood Assurance Inc

Blood Assurance Inc — FEI 1053157

The FDA completed an inspection of Blood Assurance Inc on November 1, 2023 in Cleveland, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 1, 2023
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Cleveland, TN (United States)